|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS: CHARACTERIZATION SERIES |
Division of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
Key Words. Embryonic stem cells • Imprinting • Methylation • Monkey
Correspondence: Shoukhrat M. Mitalipov, Ph.D., Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Ave., Beaverton, Oregon 97006, USA. Telephone: 503-614-3709; Fax: 503-533-2494; e-mail: mitalipo{at}ohsu.edu
Received on March 1, 2006;
accepted for publication on November 28, 2006.
First published online in STEM CELLS EXPRESS December 14, 2006.
Embryonic stem cells (ESCs) hold promise for cell and tissue replacement approaches to treating human diseases based on their capacity to differentiate into a wide variety of somatic cells and tissues. However, long-term in vitro culture and manipulations of ESCs may adversely affect their epigenetic integrity, including imprinting. We have recently reported aberrant biallelic expression of IGF2 and H19 in several rhesus monkey ESC lines, whereas SNRPN and NDN were normally imprinted and expressed predominantly from the paternal allele. The dysregulation of IGF2 and H19 that is associated with tumorigenesis in humans may result from improper maintenance of allele-specific methylation patterns at an imprinting center (IC) upstream of H19. To test this possibility, we performed methylation analysis of several monkey ESC lines by genomic bisulfite sequencing. We investigated methylation profiles of CpG islands within the IGF2/H19 IC harboring the CTCF-6 binding site. In addition, the methylation status of the IC within the promoter/exon 1 of SNURF/SNRPN known as the Prader-Willi syndrome IC was examined. Our results demonstrate abnormal hypermethylation within the IGF2/H19 IC in all analyzed ESC lines, whereas the SNURF/SNRPN IC was differentially methylated, consistent with monoallelic expression.
This article has been cited by other articles:
![]() |
R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease Brain, August 1, 2008; 131(8): 2127 - 2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dighe, L. Clepper, D. Pedersen, J. Byrne, B. Ferguson, S. Gokhale, M. C. T. Penedo, D. Wolf, and S. Mitalipov Heterozygous Embryonic Stem Cell Lines Derived from Nonhuman Primate Parthenotes Stem Cells, March 1, 2008; 26(3): 756 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Navara, J. D. Mich-Basso, C. J. Redinger, A. Ben-Yehudah, E. Jacoby, E. Kovkarova-Naumovski, M. Sukhwani, K. Orwig, N. Kaminski, C. A. Castro, et al. Pedigreed Primate Embryonic Stem Cells Express Homogeneous Familial Gene Profiles Stem Cells, November 1, 2007; 25(11): 2695 - 2704. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |